Saline Bolus: Its Purpose, Medical Uses, and Risks

A saline bolus is a rapid infusion of 0.9% sodium chloride solution, delivered intravenously over minutes rather than hours, intended to quickly expand blood volume and restore circulation. It remains one of the most common interventions in emergency and hospital medicine, used millions of times per year in settings ranging from ambulance bays to operating rooms. But the simplicity of the concept, pushing salt water into a vein, masks a surprisingly complex set of trade-offs involving how much to give, how fast, and whether saline is even the best fluid for the job.

What a Saline Bolus Actually Does in the Body

When fluid leaves the IV bag and enters your bloodstream, it temporarily increases the volume of blood your heart has to work with. The immediate goal is straightforward: more fluid in the vessels means the heart can pump more blood per beat, improving oxygen delivery to organs that may be starving for it. In healthy volunteers who received three liters of saline, stroke volume rose by about 15%, and cardiac output climbed significantly, from roughly 3.4 to 4.4 liters per minute.¹ That extra pumping capacity is what doctors are counting on when they order a bolus for someone in shock.

The heart’s response to a saline bolus is more nuanced than simply “filling a bigger tank.” One study in normal volunteers found that the increase in stroke volume came almost entirely from a roughly 26% decrease in the volume of blood left in the heart after each contraction, rather than from the heart stretching to hold more blood. Measures of the heart’s squeezing force also went up, with ejection fraction climbing from about 66% to 75%.² In other words, the heart doesn’t just passively benefit from more volume; it actively contracts harder in response.

Saline doesn’t stay in the bloodstream for long. In a conscious, healthy person, crystalloid fluids like saline have a half-life in the plasma of roughly 20 to 40 minutes, meaning half the infused volume has already migrated out of the blood vessels and into surrounding tissues within that window.³ Under stress, such as during surgery, dehydration, or blood loss, that half-life can stretch to 80 minutes or longer, which is partly why fluid given during emergencies tends to be more effective than the same volume given to someone at rest. During the actual infusion, the plasma expands 50 to 75% more than you’d predict if the fluid were distributing evenly right away, because it takes time for the fluid to leak into surrounding tissues.⁴

When Doctors Reach for a Saline Bolus

The most common emergency use is sepsis, a life-threatening response to infection where blood pressure can plummet because blood vessels dilate widely and fluid leaks out of the circulation. Guidelines generally recommend starting with a fluid bolus of around 30 milliliters per kilogram of body weight, typically saline or a similar crystalloid, delivered within the first few hours. In a large observational study, patients who received at least that much fluid had lower odds of dying in the hospital compared to those who received less.⁵ A separate multicenter cohort study found that pushing volume toward 40 to 45 mL/kg within three hours was associated with even better 28-day survival, higher rates of getting off a ventilator, and lower hospital mortality compared to the lower end of the dosing range.⁶

Beyond sepsis, saline boluses are standard for dehydration from vomiting or diarrhea, for maintaining blood pressure during and after surgery, and for keeping IV lines open so that medications can be delivered quickly. In the operating room, anesthesiologists use fluid boluses to counteract the blood-pressure-lowering effects of anesthesia. The rate of infusion matters: a study of patients undergoing major spinal surgery found that faster boluses produced a greater increase in stroke volume and blood pressure, while slower infusions sometimes failed to improve cardiac output at all.⁷

Trauma and the Case for Less Fluid

If someone is bleeding heavily from a car accident or a gunshot wound, the instinct is to pour fluid in to replace what’s being lost. For decades, that was standard practice. But a growing body of evidence suggests that aggressive fluid resuscitation in trauma can actually make bleeding worse by raising blood pressure before the bleeding source is controlled, diluting clotting factors, and disrupting clots that have already formed.⁸

This has led to the concept of permissive hypotension, a strategy in which clinicians deliberately allow blood pressure to stay somewhat below normal while focusing on stopping the source of bleeding. The aim is to keep blood pressure high enough that organs still get oxygen, but not so high that it blows out fragile new clots. A systematic review of studies in trauma patients found that those managed with this more conservative fluid approach had lower death rates than those given traditional aggressive resuscitation.⁹ Permissive hypotension is now part of what’s called “damage control resuscitation,” a bundle of strategies that also includes early use of blood products and limiting crystalloid fluid to minimize the downstream problems that too much saline creates.

Risks of Saline Boluses

Saline is often treated as harmless, basically water with salt. But 0.9% saline contains 154 millimoles per liter of chloride, which is substantially higher than what’s in your blood (normally around 96 to 106). Large volumes of saline push blood chloride levels up and drive the pH down, creating what’s called hyperchloremic metabolic acidosis.¹⁰ In a study of patients undergoing aortic surgery, those randomized to receive saline developed significantly more acidosis than those given lactated Ringer’s solution, required more bicarbonate therapy, and ended up receiving more blood products overall.¹¹

High chloride levels also affect the kidneys. Chloride triggers a feedback mechanism in the kidney that constricts blood vessels feeding the filtering units, reducing blood flow and potentially contributing to acute kidney injury. In a rat sepsis model, animals resuscitated with saline developed worse kidney injury than those given a balanced electrolyte solution, and this was consistent across kidney tissue samples, biomarkers, and clinical staging criteria.¹² The relationship between chloride and kidney damage is complex and involves multiple pathways, but the concern is real enough that it has driven an entire generation of clinical trials comparing saline to lower-chloride alternatives.¹³

Fluid overload is the other major risk. Since saline leaves the bloodstream quickly, much of a large bolus ends up in tissues. One study found that a bolus of 0.9% saline increased markers of fluid in the lungs, specifically small-airway resistance and ultrasound signs of interstitial pulmonary edema, even in healthy subjects and even before the heart showed signs of being overfilled.¹⁴ In critically ill patients, this tissue swelling can cause real harm: puffy lungs make it harder to breathe, and swollen gut tissue can impair healing after abdominal surgery.

Saline Versus Balanced Fluids

Given the chloride problem, researchers have spent years trying to determine whether balanced crystalloid solutions like lactated Ringer’s or Plasma-Lyte produce better patient outcomes than normal saline. Balanced fluids have chloride concentrations closer to blood levels and contain buffers like lactate or acetate that are metabolized into bicarbonate. In theory, they should cause less acidosis and less kidney stress.

The reality has been frustratingly ambiguous. A surgical trial of nearly 8,600 patients found that major complications occurred in about 5.8% of those given lactated Ringer’s versus 6.1% of those given saline, a difference well under half a percentage point and not statistically significant. Kidney injury rates were similarly close.¹⁵ A large hospital-wide crossover trial published in 2025 alternated entire hospitals between lactated Ringer’s and saline over multiple periods. The combined rate of death or hospital readmission within 90 days was about 20.3% with lactated Ringer’s versus 21.4% with saline, a gap that fell short of statistical significance.¹⁶

So the differences that look compelling in lab studies and in surgical populations receiving massive volumes seem to wash out in broader clinical practice, where most patients get modest amounts of fluid. That said, the trend consistently favors balanced fluids by a small margin, and there’s no scenario where saline appears to outperform them. Many hospitals and guidelines have shifted toward balanced crystalloids as a default, even if the evidence for a dramatic outcome difference is lacking.

Pediatric Boluses Are a Different Conversation

In children, the debate about fluid boluses takes on a sharper edge. The landmark FEAST trial, conducted in African children with severe infections, produced a result that stunned the critical care community: children randomized to receive a saline or albumin bolus had significantly higher 48-hour mortality than children who received no bolus at all. The saline-bolus group had a death rate of about 10.5% versus 7.3% in the group that received only maintenance fluids, a relative risk increase of 44%.¹⁷ A meta-analysis that included the FEAST data confirmed the finding, showing lower mortality in the no-bolus group among this subset of patients.¹⁸

These results are specific to resource-limited settings where mechanical ventilation and intensive monitoring may be unavailable, and they don’t straightforwardly apply to well-equipped pediatric ICUs in high-income countries. Still, they shattered the assumption that fluid boluses are universally beneficial in sick children and pushed clinicians worldwide to think more carefully about when a bolus is truly needed.

On the saline-versus-balanced-fluids question in children, a recent pediatric trial found nearly identical outcomes. Serious kidney problems or death occurred in about 3.4% of children who received balanced fluids and 3.0% who received saline, with no meaningful differences in mortality, hospital stay, or safety.¹⁹ For now, the fluid type matters less than the decision to give or withhold fluid in the first place.

Using Small Boluses as a Diagnostic Tool

Not every bolus is therapeutic. In intensive care and operating rooms, clinicians often use a “mini-fluid challenge,” a small, rapid bolus of around 100 to 150 milliliters, to test whether a patient’s heart will respond to more volume. The idea is that if the heart pumps more blood after a tiny test dose, the patient is “fluid responsive” and will benefit from a full bolus. If the heart doesn’t respond, pouring in more fluid will just cause swelling without helping circulation.²⁰

The accuracy of this approach is surprisingly good. In mechanically ventilated patients, changes in stroke volume variation and pulse pressure variation after a 100-milliliter mini-bolus predicted fluid responsiveness with an area under the curve above 0.90, which represents excellent diagnostic performance, and the gray zone of uncertain results was narrow enough to be clinically useful.²¹ The test doesn’t work perfectly in every population. In liver transplant patients, for instance, it predicted fluid responsiveness well in those with milder liver disease but failed in those with more advanced cirrhosis.²²

Restrictive Versus Liberal Strategies in Sepsis

One of the liveliest debates in critical care is whether, after the initial bolus in sepsis, you should be aggressive or restrained with additional fluids. The CLOVERS trial enrolled patients with sepsis-induced low blood pressure and randomized them after an initial one to three liters of IV fluid to either a restrictive or a liberal ongoing approach.²³ A meta-analysis pooling multiple such trials found no significant difference in 90-day mortality between restrictive and liberal strategies, and no differences in adverse events, ICU admission rates, or hospital length of stay.²⁴

That equivalence may sound like a free pass to give whatever feels right, but it’s better interpreted as evidence that the initial bolus matters most, and that the subsequent strategy should be tailored to the individual patient’s response rather than following a one-size-fits-all volume target. The observational data hint that too much fluid may increase the chance of ICU admission even while reducing mortality, which makes sense: more fluid keeps blood pressure up, which keeps the patient alive, but the excess fluid accumulates in tissues and creates its own problems that require ICU-level monitoring.⁵

Pre-Hospital Fluid and the Value of Starting Early

In the ambulance or on the scene of a medical emergency, paramedics frequently start a saline bolus before the patient reaches the hospital. Getting IV access and beginning fluid delivery in the field for severe sepsis was associated with roughly halved odds of hospital mortality in one observational study, and even establishing IV access alone without giving fluid was linked to significantly lower death rates, suggesting that the speed of subsequent treatment in the emergency department matters as much as the pre-hospital fluid itself.²⁵ The practical lesson: getting a line in early creates an option for rapid intervention even if the initial volume infused is modest.

Hypertonic Saline for Brain Injuries

Not all saline boluses use 0.9% concentration. In traumatic brain injury, doctors sometimes use hypertonic saline, solutions ranging from 3% all the way up to about 23%, to reduce dangerous swelling inside the skull. Because the salt concentration is much higher than blood, hypertonic saline pulls water out of swollen brain tissue by osmosis, lowering intracranial pressure. A meta-analysis of studies in brain-injured patients found an average 36% reduction in intracranial pressure with hypertonic saline boluses.²⁶ In patients with severely elevated pressure that hadn’t responded to other treatments, repeated boluses of 14.6% hypertonic saline dropped intracranial pressure by 30% within five minutes, and the effect lasted for about 12 hours.²⁷

These concentrated solutions require central venous access and careful monitoring. They can cause dramatic shifts in sodium levels, which brings its own set of neurological risks if managed poorly. Hypertonic saline occupies a completely different clinical niche from the standard 0.9% bolus: it’s not about filling the tank but about using osmotic force as a targeted therapy.

Saline Infusions for Chronic Conditions

Outside of emergencies, some patients receive regular saline infusions for chronic conditions. Postural tachycardia syndrome (POTS), a disorder in which the heart rate spikes abnormally when standing, is one of the better-studied examples. Patients with severe POTS who don’t respond adequately to oral fluids and medications sometimes receive intermittent IV saline infusions as a way to boost blood volume. A study of these patients found that the infusions dramatically reduced symptoms and improved quality of life.²⁸ The approach is reserved for cases where oral hydration isn’t enough, since maintaining an IV port carries infection risk and the infusions require time and medical resources.²⁹

Practical Factors That Affect How a Bolus Is Delivered

The speed of a fluid bolus depends heavily on the equipment. Catheter gauge is the biggest variable: resistance to flow increases with the fourth power of the decrease in the catheter’s internal radius, so a slightly smaller IV line slows things down dramatically. Longer tubing also increases resistance. Under gravity alone, a liter of saline through a small-gauge IV in a field setting can take a frustratingly long time. Pressure bags, which squeeze the fluid bag at around 300 mm Hg, significantly increase flow rates across all systems.³⁰ Blood products flow even more slowly than crystalloids because they’re thicker, which is one reason saline is preferred for the initial rapid volume expansion in emergencies where both are needed.³¹

Supply Chain Vulnerability

One thing most people don’t consider is that saline, despite being one of the simplest medical products imaginable, has repeatedly been in short supply. Hurricane Maria in 2017 devastated manufacturing facilities in Puerto Rico and caused a national saline shortage that forced hospitals to ration IV fluids and find workarounds for months.³² History repeated itself in 2024, when Hurricane Helene damaged a facility that supplied an estimated 60% of IV fluids in the United States, triggering another nationwide shortage.³³ These episodes expose the fragility of relying on concentrated manufacturing for a product that nearly every hospitalized patient receives. Some hospitals responded by substituting oral rehydration where possible, switching to smaller bag sizes, and diversifying their suppliers, but the underlying vulnerability of “just-in-time” delivery models hasn’t been fully resolved.